Infectious disease outbreaks 2024
Pro Research Analysisby 
Searched over 200M research papers
Global Trends in Infectious Disease Outbreaks 2024
In 2024, infectious disease outbreaks continued to pose significant challenges to global public health, with a notable increase in both the frequency and diversity of outbreaks. Vector-borne and zoonotic diseases remained prominent threats, and the rapid movement of people across borders facilitated the spread of infections worldwide. Surveillance data highlighted the need for robust monitoring and early warning systems to identify and respond to emerging threats efficiently Sun2025Luo2024.
Key Infectious Disease Outbreaks and Patterns
Vector-Borne and Zoonotic Diseases
Outbreaks of vector-borne and zoonotic diseases, such as dengue, monkeypox (Mpox), and Oropouche virus, were particularly concerning in 2024. These diseases often surged during warmer months, as hot weather accelerated the growth of bacteria and viruses, increasing the risk of water, food, and environmental contamination Sun2025Chen2024Liu2024+1 MORE. The Oropouche virus, an emerging neurotropic arbovirus, spread rapidly from Central and South America to the Caribbean, raising global awareness about the need for heightened vigilance and improved diagnostic and management strategies .
Impact of Climate and Extreme Weather Events
Extreme weather events, such as floods, played a significant role in triggering infectious disease outbreaks. In May 2024, severe flooding in southern Brazil led to a major leptospirosis outbreak, especially in urban areas with poor sanitation. These events highlighted how climate change and environmental pollution can exacerbate the spread of pathogens, emphasizing the importance of climate action and improved sanitation to mitigate future risks .
Outbreaks in Disaster and Conflict Zones
Natural disasters and armed conflicts created environments ripe for infectious disease outbreaks. After the Noto earthquake in Japan, a surge in infections was observed among evacuees, particularly in crowded shelters where COVID-19 was also prevalent. The combination of pandemic and disaster conditions increased disease severity and underscored the need for better preparedness in primary shelters . Similarly, in Gaza, the destruction of infrastructure and severe overcrowding among displaced populations led to outbreaks of scabies, lice, chickenpox, diarrheal diseases, chest infections, hepatitis A, and even polio, driven by poor sanitation and lack of clean water .
Respiratory and Community-Acquired Infections
Mycoplasma pneumonia outbreaks were detected in several countries, with increases in influenza-like illnesses and pneumonia of unknown origin starting in late 2023 and peaking in early 2024. AI-based surveillance systems, such as EPIWATCH, proved effective in providing early warning signals, allowing for more proactive outbreak management .
Advances in Surveillance and Early Warning Systems
Automated and multi-source surveillance systems demonstrated improved sensitivity and efficiency in detecting infectious disease outbreaks. In Yuhang District, China, an intelligent control platform integrated multiple data sources to generate timely warning signals, leading to earlier detection and response compared to traditional methods. This approach has significant implications for future outbreak management and public health preparedness .
Clinical Science and New Approaches
Clinical research in 2024 focused on new antibiotics and innovative prevention strategies. However, the year was marked by concerning outbreaks of dengue, measles, mpox, and highly pathogenic avian influenza A, reinforcing the ongoing need for scientific advances and global cooperation in infectious disease control .
Conclusion
The year 2024 saw a continued rise in infectious disease outbreaks, driven by factors such as climate change, global travel, natural disasters, and conflict. Vector-borne, zoonotic, and respiratory diseases were particularly prominent, and outbreaks were exacerbated by poor sanitation and overcrowding in vulnerable populations. Advances in surveillance technology and clinical science are critical for early detection, effective response, and long-term prevention of infectious diseases worldwide Sun2025Luo2024Chen2024+7 MORE.
Sources and full results
Most relevant research papers on this topic
Annual Summary of Global Infectious Diseases in 2024
Infectious diseases pose a major public health challenge, with vector-borne and zoonotic diseases emerging as major threats, requiring effective prevention, control, and monitoring strategies to combat the rising global incidence and prevalence.
Global Infectious Diseases between July and September 2024: Periodic Analysis
Infectious diseases like monkeypox, dengue, cholera, and measles are more likely to spread during the summer months of 2024 due to increased temperatures and increased contamination of water, food, and the environment.
Extreme Weather Events and Pathogen Pollution Fuel Infectious Diseases: The 2024 Flood-Related Leptospirosis Outbreak in Southern Brazil and Other Red Lights
Extreme weather events and pathogen pollution contribute to infectious disease outbreaks, highlighting the need for climate change mitigation and improved sanitation systems to mitigate this issue.
Epidemic Signals of Mycoplasma Pneumonia outbreaks in 2023 and early 2024 using Artificial Intelligence System (EPIWATCH®)
EPIWATCH® effectively provides timely early signals of Mycoplasma pneumonia outbreaks, aiding in understanding and managing emerging infectious diseases.
Analysis of Infectious Diseases in Himi City, Japan, During the Noto Earthquake in 2024 Amid the Ongoing COVID-19 Pandemic
A combined pandemic and earthquake disaster may worsen disease severity, highlighting the need for primary shelters to prepare for potential infectious disease outbreaks.
What's Hot This Year in Infectious Diseases Clinical Science
Infectious diseases clinical science made rapid progress in 2024, with multiple trials of new antibiotics and prevention approaches, highlighting the need for further advances in clinical science.
DOI